ASMB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Assembly Biosciences Inc (ASMB) does not present a compelling buy opportunity for a beginner investor with a long-term strategy at this time. While there are some positive indicators such as hedge fund buying and bullish moving averages, the lack of strong financial performance, absence of news catalysts, and no recent trading signals suggest that holding off on investment may be a prudent choice.
The technical indicators show a bullish trend with moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram of 0.518. RSI is neutral at 61.082, and the price is approaching the first resistance level (R1: 29.93). However, there is no strong momentum to suggest a breakout.
Hedge funds are significantly increasing their buying activity, up 161.98% over the last quarter. Bullish moving averages suggest an upward trend.
No recent news or significant insider trading activity. Financial performance shows a decline in net income (-4.34% YoY) and EPS (-52.32% YoY). No recent congress trading data or analyst rating trends available.
In Q3 2025, revenue increased by 57.62% YoY to $10.79M, but net income dropped to -$9.19M (-4.34% YoY), and EPS fell significantly to -0.72 (-52.32% YoY). Gross margin remained flat at 100%.
No data available for analyst rating or price target trends.
